The first 12 months of COVID-19: a timeline of immunological insights
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Breaking newsCOVID-19ResearchThe serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue -
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
-
Breaking newsCOVID-19Research
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies -
Breaking newsCOVID-19ResearchNeurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome
Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome -
Breaking newsCOVID-19Research
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19
Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19 -
Immunogenicity of the Ad26.COV2.S vaccine for COVID-19 -
Breaking newsCOVID-19ResearchAssociation of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19
Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19 -
Breaking newsCOVID-19Research
Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Four-month clinical status of a cohort of patients after hospitalization for COVID-19 -
Breaking newsCOVID-19Research
EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes
EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes -
Breaking newsCOVID-19ResearchAssociation of convalescent plasma treatment with clinical outcomes in patients with COVID-19 a systematic review and meta-analysis
Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19 a systematic review and meta-analysis -
Breaking newsCOVID-19Research
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 -
Breaking newsCOVID-19ResearchAzithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial -
SARS-CoV-2 within-host diversity and transmission
-
Breaking newsCOVID-19Research
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England